Ignite Creation Date:
2024-05-05 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00272415
Status:
TERMINATED
Last Update Posted:
2009-03-11
First Post:
2006-01-03
Brief Title:
A Study of Intravenous INO-1001 Plus Oral Temozolomide to Evaluate Tolerability Safety and Pharmacokinetics in Patients With Melanoma
Sponsor:
Genentech Inc
Organization:
Genentech Inc
Organization Data
Organization:
Genentech Inc
Class:
INDUSTRY
Study ID:
IPC-06-2004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Genentech Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Clinical Trials Posting Group
Old Organization:
Genentech Inc